← Back
$OCUL All transactions

OCULAR THERAPEUTIX, INC

▼ SELL

$ Value

$23K

Shares

2,810

Price

$8

Filed

Feb 25

Insider

Name

Kaiser Peter

Title

Chief Development Officer

CIK

0002011869

Roles

Officer

Transaction Details

Transaction Date

2026-02-23

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

269,108

Footnotes

Represents shares of common stock of Ocular Therapeutix, Inc. (the "Corporation") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on April 9, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on February 22, 2026. The sales do not represent a discretionary trade by the reporting person. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.2300 to $8.3600, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Filing Info

Accession No.

0001104659-26-019804

Form Type

4

Issuer CIK

0001393434

Kaiser Peter's History

Date Ticker Type Value
2026-02-23 OCUL $23K
2026-01-02 OCUL A $0
2026-01-02 OCUL A $0
2025-11-24 OCUL $36K
2025-10-02 OCUL $106K
2025-08-25 OCUL $36K
2025-05-23 OCUL $21K

Other Insiders at OCUL (90d)

Insider Bought Sold Last
LINDSTROM RICHARD L MD $461K 2026-02-20
Heier Jeffrey S.
Chief Scientific Officer
$25K 2026-02-23
Dugel Pravin
See Remarks
$1.3M 2026-04-09
Notman Donald
Chief Operating Officer
$205K 2026-02-12
Nayak Sanjay
Chief Strategy Officer
$108K 2026-02-23
Waheed Nadia
Chief Medical Officer
$98K 2026-02-20
Robinson David Wayne
Global CCO
2026-01-21